Health Care

Syngene reported a 5% rise in its net profit for Q3FY23

● Jan 24, 2023

Syngene International reported a 5.5% rise in consolidated net profit to INR 109.70 crore in Q3 FY23 as against INR104...

Syngene International Ltd (SYNGENE) Q3 FY23 Earnings Concall Transcript

● Jan 24, 2023

Syngene International Ltd  (NSE: SYNGENE) Q3 FY23 Earnings Concall dated January 24, 2023 Corporate Participants: Avantika Mishra — Associate – EY Jonathan...

Gland Pharma Limited Q3 FY23 Earnings Conference Call Insights

● Jan 24, 2023

Key highlights from Gland Pharma Limited (GLAND) Q3 FY23 Earnings Concall Management Update: [00:06:08] GLAND said the insulin line is...

Shares of Biocon research arm soars as it reports 23% rise in its revenue

● Jan 24, 2023

Syngene International reported a 5.5% rise in consolidated net profit to INR 109.70 crore in Q3 FY23 as against INR104...

Gland Pharma Limited (GLAND) Q3 FY23 Earnings Concall Transcript

● Jan 23, 2023

Gland Pharma Limited (NSE:GLAND) Q3 FY23 Earnings Concall dated Jan. 23, 2023. Corporate Participants: Sumanta Bajpayee — Vice President, Finance and Investor...

SBI LIFE INSURANCE CO LTD (SBILIFE) Q3 FY23 Earnings Concall Transcript

● Jan 21, 2023

SBI LIFE INSURANCE CO LTD (NSE: SBILIFE) Q3 FY23 Earnings Concall dated Jan. 21, 2023 Corporate Participants: Mahesh Kumar Sharma — Managing...

Shalby Ltd. Q3FY23; 18% Growth in Profits

● Jan 17, 2023

Shalby Ltd.‘s revenues in Q3FY23 rose 25% to ₹ 2,067 millions. Consolidated Profit After Tax came at ₹ 153 millions...

Shalby Limited Q3FY23 Earnings Story

● Jan 17, 2023

Shalby Ltd. is a leading chain of multispecialty hospitals and tertiary care centers in India. In the Hospital business, the company...

Apollo Hospitals: Ushering in a New Era

● Jan 9, 2023

“Our hospital business is on a very strong growth trajectory and will continue to grow. We will improve not only...

Marksans Pharma(NSE:MARKSANS): Everything You Need to Know | Stock up 30% in 3 Months

● Jan 4, 2023

Marksans Pharma (NSE:MARKSANS) is a mid-sized pharmaceutical company with a large presence in the US, UK, Australia, and New Zealand...